Trials / Conditions / Metastatic Non-squamous Non Small Cell Lung Cancer

Metastatic Non-squamous Non Small Cell Lung Cancer

8 registered clinical trials studyying Metastatic Non-squamous Non Small Cell Lung Cancer — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Me NCT07246863	CatalYm GmbH	Phase 2
Recruiting	Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Met NCT07098988	CatalYm GmbH	Phase 2
Recruiting	Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint NCT06463665	Genelux Corporation	Phase 2
Recruiting	JAB-21822 Combined With JAB-3312 Compared SOC in the First Line for Treatment of Advanced Non-small Cell Lung NCT06416410	Allist Pharmaceuticals, Inc.	Phase 3
Not Yet Recruiting	Efficacy and Safety of Nab-paclitaxel-Lenvatinib-Pembrolizumab as Second-line Treatment in Advanced NSCLC Pati NCT06028633	Peking University First Hospital	Phase 2
Terminated	Study of Pemetrexed+Platinum Chemotherapy With or Without Cosibelimab in First Line Metastatic Non-squamous NS NCT04786964	Checkpoint Therapeutics, Inc.	Phase 3
Completed	Phase 3 Study of Sitravatinib Plus Nivolumab vs Docetaxel in Patients With Advanced Non-Squamous Non-Small Cel NCT03906071	Mirati Therapeutics Inc.	Phase 3
Completed	Triplet Combination First Line Treatment in Non Small Cell Lung Cancer (NSCLC) NCT00942825	CanBas Co. Ltd.	Phase 2